marimastat has been researched along with Ehlers-Danlos Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sastry, PS | 1 |
1 other study(ies) available for marimastat and Ehlers-Danlos Syndrome
| Article | Year |
|---|---|
Matrix metalloproteinase inhibitor therapy to prevent complications as well as therapy for Ehler-Danlos syndrome.
Topics: Ehlers-Danlos Syndrome; Humans; Hydroxamic Acids; Matrix Metalloproteinase Inhibitors; Protease Inhibitors | 2002 |